USANA HEALTH SCIENCES, INC. Other Receivables, Net, Current
USANA HEALTH SCIENCES, INC. (USNA) had Other Receivables, Net, Current of $8.09 million as of 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Nontrade Receivables › Other Receivables, Net, Current
us-gaap:OtherReceivablesNetCurrent · last filed 2026-03-16
- 2026-01-03: Other Receivables, Net, Current $8.09M.
- 2024-12-28: Other Receivables, Net, Current $7.42M.
- 2023-12-30: Other Receivables, Net, Current $6.17M.
- 2022-12-31: Other Receivables, Net, Current $5.18M.
| Period end | Other Receivables, Net, Current | Other Receivables, Net, Current as first filed |
|---|---|---|
| 2026-01-03 | $8.09M 10-K · filed 2026-03-16 | |
| 2024-12-28 | $7.42M 10-K · filed 2026-03-16 | |
| 2023-12-30 | $6.17M 10-K · filed 2025-03-12 | |
| 2022-12-31 | $5.18M 10-K · filed 2024-02-27 | |
| 2022-01-01 | $5.58M 10-K · filed 2023-02-28 | |
| 2021-01-02 | $6.25M 10-K · filed 2022-03-01 | |
| 2019-12-28 | $6.72M 10-K · filed 2021-03-02 | |
| 2018-12-29 | $7.63M 10-K · filed 2020-02-25 | |
| 2017-12-30 | $4.78M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $4.26M 10-K · filed 2018-02-28 | |
| 2016-01-02 | $4.70M 10-K · filed 2017-03-01 | |
| 2015-01-03 | $3.66M 10-K · filed 2016-03-01 | $5.51M 10-K · filed 2015-03-17 |
| 2013-12-28 | $7.01M 10-K · filed 2015-03-17 | |
| 2012-12-29 | $3.37M 10-K · filed 2014-03-13 | |
| 2011-12-31 | $2.98M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |